Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus late epidural anaesthesia activation during gastroesophageal resection
2014-002036-14Phase 4Completed
- Sponsor
- Lars Bo Svendsen
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine, lidocaine, morphine and norepinephrine in gastroesophageal junction adenocarcinoma (2 arms), sponsored by Lars Bo Svendsen. Primary endpoint: Alterations in gastric conduit microcirculation. Started Jun 2014; status: completed.
02
Drugs
bupivacainelidocainemorphinenorepinephrine
03
Conditions
gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on 2014-002036-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002036-14.